Life Sciences

The male and female hormone tests are the first product in the company's Kind at Home consumer products division.

The company is expanding to other Asian markets starting this year.

Over 100 clinics have already joined WellAway since the company received its license last year.

Also: AI-enabled documentation tool DeepScribe raises $30 million, cancer risk stratification platform PreciseDx scores $10.75 million and care navigation startup HeyRenee brought in $4.4 million.

Also: Overjet hires Dr. Teresa Dolan as chief dental officer, Valo Health appoints Dr. Dave Morris as chief medical officer and AliveCor adds four new people to its executive team.

This news comes just months after Exscientia went public. 

The company plans to use the funding to expand its commercial team, scale operations and develop new products.

The test reports on the G84E mutation in the HOXB13 gene, which studies have shown increase a person’s risk of developing prostate cancer.

Also: Medicare Advantage insurer Zing Health partners with Papa. Verily and biopharma-company Sosei Heptares announce a research collaboration. Pharma-focused accelerator PharmStars’ next cohort will focus on neurological diseases.

Also: Ghanian startup mPharma raises $35 million, and child RPM maker Kiddo scoops up $16 million.